REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

DUNAKESZI-AGNES Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DUNAKESZI-AGNES Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

DUNAKESZI-AGNES Kft. is an enterprise based in Hungary. Its main office is in Dunakeszi. It operates in the Pharmacies and Drug Stores industry. It was first established on August 18, 2009. It currently has a total number of 3 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 9.61% in 2024. A growth of 11.65% was recorded in its total assets. In 2024, DUNAKESZI-AGNES Kft.’s net profit margin increased by 0.36%.

Headquarters
Foti ut 77.
Dunakeszi; Pest; Postal Code: 2120

Contact Details: Purchase the DUNAKESZI-AGNES Kft. report to view the information.

Website: http://agnesdunakeszi.novodata.hu/

Basic Information
Total Employees:
Purchase the DUNAKESZI-AGNES Kft. report to view the information.
Registered Capital:
Purchase the DUNAKESZI-AGNES Kft. report to view the information.
Financial Auditors:
Purchase the DUNAKESZI-AGNES Kft. report to view the information.
Incorporation Date:
August 18, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after DUNAKESZI-AGNES Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.61%▲
Total operating revenue
10.06%▲
Operating profit (EBIT)
34.87%▲
EBITDA
28.91%▲
Net Profit (Loss) for the Period
26.95%▲
Total Assets
11.65%▲
Total Equity
14.32%▲
Operating Profit Margin (ROS)
0.59%▲
Net Profit Margin
0.36%▲
Return on Equity (ROE)
1.24%▲
Quick Ratio
0.95%▲
Cash Ratio
0.99%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo